Advertisement
U.S. Markets closed

Myriad Genetics, Inc. (MYGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
15.25-0.43 (-2.74%)
At close: 04:00PM EST
15.25 0.00 (0.00%)
After hours: 04:37PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close15.68
Open15.80
Bid15.19 x 700
Ask15.32 x 300
Day's Range15.18 - 15.80
52 Week Range15.18 - 29.30
Volume876,227
Avg. Volume760,462
Market Cap1.388B
Beta (5Y Monthly)1.94
PE Ratio (TTM)N/A
EPS (TTM)-1.28
Earnings DateNov 07, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est24.92
  • Zacks

    MYGN Stock Might Gain From SneakPeek Availability in Retail Stores

    Myriad Genetics announces the availability of SneakPeek - the first at-home early fetal sex test in Walmart, Walgreens and CVS stores nationwide.

  • GlobeNewswire

    Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch

    SneakPeek®, the first at-home early fetal sex test for use at six weeks, is now available at over 8,800 retail locations nationwideSALT LAKE CITY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to prenatal testing. SneakPeek, the #1 OBGYN-recommended gender test with over 99% accuracy,[1] is now available over the counter in more than 8,800 retail locations nationwide.